# Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals

> **NCT01201577** · PHASE1 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 40 (estimated)

## Conditions studied

- Quorum Sensing
- Prebiotics
- Probiotics
- Sepsis

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium longum BB536
- **DIETARY_SUPPLEMENT:** Active hexose correlated compound (AHCC)
- **DIETARY_SUPPLEMENT:** Bifidobacterium longum BB536 and Active hexose correlated compound (AHCC)
- **DIETARY_SUPPLEMENT:** Corn starch placebo capsule
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT01201577
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201577, "Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01201577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*